Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton ‐pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea

ConclusionsPAM‐B therapy is as effective as concomitant therapy for eradicating H. pylori with comparative safety. PAM‐B therapy is regarded as a promising alternative to standard triple therapy for a first‐line eradication in Korea.

Source: Helicobacter - January 25, 2018 Category: Gastroenterology Authors: Jung Wan Choe, Sung Woo Jung, Seung Young Kim, Jong Jin Hyun, Young Kul Jung, Ja Seol Koo, Hyung Joon Yim, Sang Woo Lee Tags: ORIGINAL ARTICLE Source Type: research